Article
Fibroblast-derived osteoglycin promotes epithelial cell repair
25 Mar 2025
Abstract excerpt
There is an urgent need for innovative therapies targeting defective epithelial repair in chronic diseases like COPD. The mesenchymal niche is a critical regulator in epithelial stem cell activation, suggesting that their secreted factors are possible potent drug targets. Utilizing a proteomics-guided drug discovery strategy, we explored the lung fibroblast secretome to uncover impactful drug targets. Our lung...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
